Trial Profile
An observational study investigating the effect of mizoribine versus mycophenolate mofetil as post-transplational immunosuppressive regimens in kidney transplant patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2015
Price :
$35
*
At a glance
- Drugs Mizoribine (Primary) ; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 29 Dec 2015 New trial record